PRMs Collaborative Conversation Series - Dr Tamara Crittenden
Dr Tamara Crittenden
Research Coordinator the SALHN Department of Plastic and Reconstructive Surgery at Flinders Medical Centre
- SALHN Department of Plastic and Reconstructive Surgery
- Flinders Medical Centre; Academic Status Holder
- College of Medicine and Public Health, Flinders University
- Member of the CEIH Patient Reported Measures (PRMs) South Australian Generic PROM Selection Sub-Committee
Q&A with Tamara
What interested you about patient reported measures research and/or projects?
The primary focus of the projects I co-ordinate is the collection and interpretation of evidence to support continuous improvement activities and in the practice of evidence-based medicine to deliver quality clinical management and best outcomes for patients undergoing reconstructive surgery. Patient-reported outcome measures (PROMs) are widely used in these projects across several key areas of this specialty including reconstructive breast surgery, head and neck cancer, cleft lip and palate, skin cancer, and hand surgery. PROMs continue to play an integral role in these studies for obtaining valuable health-related quality of life and health outcomes data from the patient’s perspective.
I am currently involved in several key international collaborations using PROMs including the OECD Patient-Reported Indicators Surveys (PaRIS) initiative for breast cancer patient outcomes, and with leading researchers at McMaster University (Canada), Memorial Sloan Kettering Cancer Center and Harvard University (United States).
What is your biggest achievement in relation to patient reported measures research, or the application of research into practice?
In 2020, I completed a PhD which centred on the use of PROMs to demonstrate the clinical- and cost-effectiveness of breast reduction surgery in the Australian health care system. One of my biggest achievements was being awarded the Higher Research Degree Student Research Impact Prize as a recognition of the quality and impact of this research. Importantly, this work provided the high-quality evidence to successfully inform state and national healthcare policy and circumvent the loss of this important surgical procedure for women from the Australian Medicare system.
- Crittenden TA, Ratcliffe J, Watson DI, Mpundu-Kaambwa C, Dean NR. Cost-utility analysis of breast reduction surgery for women with symptomatic breast hypertrophy. The Medical Journal of Australia. 2022;216(3):147 – 52.
- Crittenden TA, Watson DI, Ratcliffe J, Griffin PA, Dean NR. Outcomes of Breast Reduction Surgery Using the BREAST‑Q: A Prospective Study and Comparison with Normative Data. Plastic and Reconstructive Surgery. 2019;144(5):1034 – 44.
How do you approach collaboration with consumers, carers and community? Or how do think we can work together to keep making advancements in this space?
In addition to the collection of the patient perspective through PROMs, we recognise the importance of collaboration with consumers, carers, and the community. I am involved in consumer groups for several of our projects including the breast reconstruction and the hand surgery consumer group forums. These meetings provide an opportunity to partner with consumers and gain valuable feedback to inform quality patient-centred care.
View Tamara’s profile via the Flinders University website: https://researchnow.flinders.edu.au/en/persons/tamara-crittenden.
View other profiles in the PRMs Collaborative Conversation Series.